Open AccessAnti-proliferative and anti-migratory effects of EGFR and c-Met tyrosine kinase inhibitors in triple negative breast cancer cells
Author(s) -
Cory Lefebvre,
Alison L. Allan
Publication year - 2021
Publication title -
precision cancer medicine
Language(s) - English
Resource type - Journals
ISSN - 2617-2216
DOI - 10.21037/pcm-20-62
Subject(s) - erlotinib , cabozantinib , triple negative breast cancer , cancer research , c met , egfr inhibitors , epidermal growth factor receptor , breast cancer , erlotinib hydrochloride , tyrosine kinase inhibitor , cancer , receptor tyrosine kinase , hepatocyte growth factor , biology , medicine , receptor , vegf receptors